Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer Unrecognized Tax Benefits (UTB) by Year
Unrecognized Tax Benefits (UTB) — Ending gross balance ($M) ($M)
Pfizer Unrecognized Tax Benefits (UTB): $4,746M in FY2025, up 4.8% from a year earlier.
Latest, FY2025
4,746
Period ended Dec 31, 2025
Change on a year earlier
+4.8%
4,530 in FY2024
History
11 years
Since FY2015
Sources
8
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-Q / 10-K Taxes on Income Footnote.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Unrecognized Tax Benefits (UTB) — Ending gross balance ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,746 | +4.8% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 4,530 | -5.7% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 4,802 | +6.9% | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 4,494 | -25.9% | Form 10-K (filed 2026-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 6,068 | +8.5% | Form 10-K (filed 2025-02-27) ↗ |
| FY2020 | Dec 31, 2020 | 5,595 | +4.0% | Form 10-K (filed 2024-02-22) ↗ |
| FY2019 | Dec 31, 2019 | 5,381 | -14.0% | Form 10-K (filed 2023-02-23) ↗ |
| FY2018 | Dec 31, 2018 | 6,259 | -4.6% | Form 10-K (filed 2022-02-24) ↗ |
| FY2017 | Dec 31, 2017 | 6,558 | +12.6% | Form 10-K (filed 2021-02-25) ↗ |
| FY2016 | Dec 31, 2016 | 5,826 | -1.6% | Form 10-K (filed 2020-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 5,919 | – | Form 10-K (filed 2019-02-28) ↗ |
Breakdown
What makes up unrecognized Tax Benefits (UTB)
- GAAP Effective Income Tax Rate (%)-350.0% · FY2025
- UTB additions — Current year tax positions ($M)375 · FY2025
- UTB additions — Prior year tax positions ($M)298 · FY2025
- UTB reductions — Prior year tax positions ($M)197 · FY2025
- UTB reductions — Settlements with taxing authorities ($M)112 · FY2025
- Accrued interest & penalties on unrecognized tax benefits ($M)681 · FY2025
Cite this data
StockData. (2026). Pfizer Unrecognized Tax Benefits (UTB) ($M), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/utb-bal
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.